Phio Pharmaceuticals to Participate in Renmark Financial Communications Virtual Non-Deal Roadshow Series
Phio Pharmaceuticals Corp. to Present at the Virtual Non-Deal Roadshow Series Presentation Details Thursday, September 5, 2024 Marlborough, Massachusetts–(Newsfile Corp. – August 29, 2024) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, announced…